logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
26/09/2025
Ideal i6 had a strong performance in order bookings after being launched this afternoon. As of the time of writing, this car has already received over 20,000 confirmed orders. According to Ideal's sales policy, the confirmed order for Ideal i6 allows consumers to modify configurations or apply for a refund within 7 days of paying the deposit; after 7 days, the deposit is non-refundable. (latepost)
Latest
2 m ago
China Medical Technology (08156.HK) announces annual performance. The company's owners are expected to incur a loss of approximately HK$900,000, a significant decrease of about 95% year on year.
2 m ago
WTT China Grand Slam: All 7 members of the Chinese national team won their qualification matches the next day.
3 m ago
According to documents from the Hong Kong Stock Exchange, Jiangsu Slender West Lake Cultural Tourism Co., Ltd. has submitted an application for listing on the Hong Kong Stock Exchange.
3 m ago
WTI crude oil futures rose 2.00% intraday, now trading at $66.28 per barrel.
4 m ago
Pharmaceutical company Crinetics Pharmaceuticals soared 26.6% in early trading, receiving approval from the US FDA for its treatment drug Palsonify for acromegaly. The approval was based on successful phase three trials, and the product is scheduled to be launched in early October. This marks an important milestone for Crinetics in the field of rare disease treatment.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.